Inhibitory Activity Against Epidermal Growth Factor Receptor (EGFR) Based on Single Point Mutations of Active Site Residues

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|10|3|252-270

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.10, Iss.3, 2014-05, pp. : 252-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)

By  

Medicinal Chemistry, Vol. 7, Iss. 1, 2011-01 ,pp. : 24-31

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Elucidation of Unique Inhibitory Activities of Two Thiazolo[ 4,5-d]pyrimidines Against Epidermal Growth Factor Receptor (EGFR): Implications for Successful Drug Design

By  

Medicinal Chemistry, Vol. 10, Iss. 1, 2014-01 ,pp. : 46-58

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Molecular Imaging: Radionuclide-Based Biomarkers of the Epidermal Growth Factor Receptor (EGFR)

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 18, 2007-09 ,pp. : 1755-1772

Bentham Science Publishers

Access to resources Recommend Favorite

Acneiform folliculitis associated with epidermal growth factor receptor (EGFR) inhibitors requires sympathetic treatment of mild, as well as severe, symptoms

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 6, 2009-06 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

The risk of keratitis previously identified with panitumumab is now considered a class effect for all epidermal growth factor receptor (EGFR) inhibitors

By  

Reactions Weekly, Vol. 1, Iss. 1405, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite